TLR7 and autoimmune disease: Another study focused on TLR7/8 showed that topical application of the TLR7/8 agonist resiquimod (R848) in SU5416 rats exhibited severe symptoms of PH and autoimmune disorders, implicating the immunopathological link of autoimmune vasculopathy [127].